Across TCGA pan-cancer cohorts, RNU1-28P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU1-28P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU1-28P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU1-28P is over-expressed in tumor.

STAD and LUAD are the cancer types where RNU1-28P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-28P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	III,IV	+0.919	.041	1	view →
LUAD	All	All	+0.254	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU1-28P RNA expression & survival · all RNU1-28P data types